Novartis enrolled 340 subjects with biopsy-proven IgAN and proteinuria levels of a minimum of 1 g/day in the trial. Credit: Michael Derrer Fuchs / Shutterstock.com. Novartis has unveiled interim ...

Pegcetacoplan was found to be well-tolerated in the trial in adults with post-transplant recurrence of C3G or IC-MPGN. Credit: sweet_tomato / Shutterstock.com. Apellis Pharmaceuticals and Sobi have ...

Avutometinib won orphan drug designation from the US Food and Drug Administration (FDA) in March 2024. The agency designated ...

Eight patients undergoing haemodialysis were enrolled into the first in human trial which demonstrated safety and efficacy of ...

Kelly Franchetti discusses the evolving role of patient advocates and the key relationships needed to advance drug ...

Merck has discontinued a trial investigating a coformulation of vibostolimab and pembrolizumab for patients with resected ...

Heartbeam AI plus vectorcardiography (VCG) outperformed an expert panel of three cardiologists by 40% in detecting atrial ...

Patient-friendlier progesterone administration for luteal phase support is another unmet need in the female infertility ...

On Clinical Trials Day, we take a look at how sponsors are exploring alternative designs to study cell and gene therapies.

The POETYK PSO long-term extension trial assessed Sotyktu in treating moderate-to-severe plaque psoriasis. Credit: ...

Terran Biosciences is waiting for KarXT to receive approval from the FDA before initiation two Phase I trials of its prodrug TerXT. Image credit: New Africa / Shutterstock. Terran Biosciences is ...

Johnson & Johnson’s and subsidiary Janssen have both applied for regulatory approval for Tremfya to the EMA and FDA. Image credit: Shutterstock / Skorzewiak. Johnson and Johnson’s Tremfya (guselkumab) ...